Header Logo

Connection

Theodore Levin to Mass Screening

Back to Details
This is a "connection" page, showing publications Theodore Levin has written about Mass Screening.
Theodore Levin
Connection Strength
4.553
Mass Screening
  1. Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol. 2017 01; 112(1):8-10.
    View in: PubMed
    Score: 0.373
  2. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012 Sep; 143(3):844-857.
    View in: PubMed
    Score: 0.276
  3. Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care. 2012 Jul; 18(7):370-8.
    View in: PubMed
    Score: 0.276
  4. The importance of choosing colorectal cancer screening tests: comment on "Adherence to colorectal cancer screening". Arch Intern Med. 2012 Apr 09; 172(7):582-3.
    View in: PubMed
    Score: 0.272
  5. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33:101-10.
    View in: PubMed
    Score: 0.257
  6. Editorial: It's time to make organized colorectal cancer screening convenient and easy for patients. Am J Gastroenterol. 2009 Apr; 104(4):939-41.
    View in: PubMed
    Score: 0.220
  7. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005 Jun; 54(6):807-13.
    View in: PubMed
    Score: 0.169
  8. Colonoscopy capacity: Can we build it? Will they come? Gastroenterology. 2004 Dec; 127(6):1841-4.
    View in: PubMed
    Score: 0.163
  9. Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med. 2004 Mar; 38(3):276-83.
    View in: PubMed
    Score: 0.155
  10. Could screening for colorectal cancer be harmful? Am J Gastroenterol. 2002 Jan; 97(1):198.
    View in: PubMed
    Score: 0.133
  11. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. CA Cancer J Clin. 2020 07; 70(4):283-298.
    View in: PubMed
    Score: 0.120
  12. What Is Organized Screening and What Is Its Value? Gastrointest Endosc Clin N Am. 2020 Jul; 30(3):393-411.
    View in: PubMed
    Score: 0.118
  13. Colorectal cancer screening: new opportunities. Surg Oncol Clin N Am. 1999 Oct; 8(4):673-91, vi-vii.
    View in: PubMed
    Score: 0.114
  14. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study. Ann Intern Med. 2019 07 02; 171(1):19-26.
    View in: PubMed
    Score: 0.112
  15. Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. BMC Cancer. 2018 May 02; 18(1):509.
    View in: PubMed
    Score: 0.103
  16. Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test. JAMA. 2017 08 01; 318(5):483.
    View in: PubMed
    Score: 0.098
  17. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 Jul; 112(7):1016-1030.
    View in: PubMed
    Score: 0.097
  18. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep; 53(3):335-344.
    View in: PubMed
    Score: 0.096
  19. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 03; 62(3):678-688.
    View in: PubMed
    Score: 0.094
  20. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8.
    View in: PubMed
    Score: 0.090
  21. Colorectal cancer screening: 80% by 2018. Colonoscopists simply cannot do it alone. Gastrointest Endosc. 2016 Mar; 83(3):552-4.
    View in: PubMed
    Score: 0.089
  22. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
    View in: PubMed
    Score: 0.088
  23. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1.
    View in: PubMed
    Score: 0.082
  24. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 Apr 03; 370(14):1287-97.
    View in: PubMed
    Score: 0.078
  25. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.072
  26. Implications of new colorectal cancer screening technologies for primary care practice. Med Care. 2008 Sep; 46(9 Suppl 1):S138-46.
    View in: PubMed
    Score: 0.053
  27. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008 May-Jun; 58(3):130-60.
    View in: PubMed
    Score: 0.051
  28. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008 May; 134(5):1570-95.
    View in: PubMed
    Score: 0.051
  29. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007 Oct 03; 99(19):1462-70.
    View in: PubMed
    Score: 0.050
  30. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024 Jul 01; 7(7):e2423671.
    View in: PubMed
    Score: 0.040
  31. Screening in liver disease: report of an AASLD clinical workshop. Hepatology. 2004 May; 39(5):1204-12.
    View in: PubMed
    Score: 0.039
  32. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults. Ann Intern Med. 2024 Apr; 177(4):542-543.
    View in: PubMed
    Score: 0.039
  33. Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing. Cancer Epidemiol Biomarkers Prev. 2024 Feb 06; 33(2):215-223.
    View in: PubMed
    Score: 0.039
  34. What does sigmoidoscopy really miss? Am J Gastroenterol. 2003 Oct; 98(10):2326-7.
    View in: PubMed
    Score: 0.038
  35. Does Screening Colonoscopy Have a Future in the United States? Clin Gastroenterol Hepatol. 2023 11; 21(12):3005-3010.
    View in: PubMed
    Score: 0.037
  36. Re: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003 Jun 04; 95(11):830-1; author reply 831.
    View in: PubMed
    Score: 0.037
  37. Does family history still matter in the era of screening colonoscopy? Clin Gastroenterol Hepatol. 2003 Mar; 1(2):69-70.
    View in: PubMed
    Score: 0.036
  38. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003 Feb; 124(2):544-60.
    View in: PubMed
    Score: 0.036
  39. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
    View in: PubMed
    Score: 0.036
  40. Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):22-29.
    View in: PubMed
    Score: 0.036
  41. Complications of screening flexible sigmoidoscopy. Gastroenterology. 2002 Dec; 123(6):1786-92.
    View in: PubMed
    Score: 0.035
  42. Flexible sigmoidoscopy for colorectal cancer screening: valid approach or short-sighted? Gastroenterol Clin North Am. 2002 Dec; 31(4):1015-29, vii.
    View in: PubMed
    Score: 0.035
  43. Flexible sigmoidoscopy: an important screening option for average-risk individuals. Gastrointest Endosc Clin N Am. 2002 Jan; 12(1):23-40, vi.
    View in: PubMed
    Score: 0.033
  44. The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer. J Med Screen. 2021 06; 28(2):140-147.
    View in: PubMed
    Score: 0.030
  45. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5.
    View in: PubMed
    Score: 0.021
  46. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer. Gastrointest Endosc. 2014 Oct; 80(4):543-562.
    View in: PubMed
    Score: 0.020
  47. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology. 2004 Sep; 127(3):714-22.
    View in: PubMed
    Score: 0.010
  48. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
    View in: PubMed
    Score: 0.008

© 2024 Kaiser Permanente